Citigroup Inc Foghorn Therapeutics Inc. Transaction History
Citigroup Inc
- $150 Billion
- Q1 2024
A detailed history of Citigroup Inc transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Citigroup Inc holds 3,385 shares of FHTX stock, worth $18,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,385
Previous 2,933
15.41%
Holding current value
$18,414
Previous $18,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding FHTX
# of Institutions
70Shares Held
23.6MCall Options Held
7.7KPut Options Held
1.4K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$68.9 Million5.6% of portfolio
-
Raymond James & Associates St Petersburg, FL2.23MShares$12.1 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$8.56 Million1.36% of portfolio
-
Black Rock Inc. New York, NY1.32MShares$7.16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$6 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $227M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...